Pg 23: Lincosamides (Clindamycin & Lincomycin)

Back to: Pharmacology Mnemonics for ADC Therapeutic Guidelines (2012)

Course Syllabus

Antimicrobials
- Pg 17- Table 1: Common antimicrobial Drugs used in Dentistry
- pg 19- penicillin hypersensitivity
- Pg 20: Antibiotic-associated Diarrhea
- pg 20: Antimicrobial Drug Interactions
Penicillins
- Pg 21: Narrow Spectrum Penicillins (Phenoxymethylpenicillin, Benzylpenicillin)
- PG 21: Narrow-spectrum penicillins with antistaphylococcal activity (Dicloxacillin, Flucloxcacillin)
- Continued: Dicloxacillin/ Flucloxacillin
- Pg 22: Moderate spectrum penicillins (Amoxicillin, Ampicillin)
- Pg 22: Broad-spectrum penicillins (beta-lactamase inhibitor combinations): Amoxycillin+clavulanate
Cephalosporins
- Pg 22: Cephalosporins (Cephalexin & Cephazolin)
Glycopeptides
- Pg 23: Glycopeptides (Teicoplanin & Vancomycin)
Lincosamides
- Pg 23: Lincosamides (Clindamycin & Lincomycin)
Macrolides
- pg 24: Macrolides
Nitroimidazoles
- Pg 24: Nitroimidazoles (Part 1) (Tinidazole, Metronidazole)
- Continued: Nitroimidazoles (Part 2) (Tinidazole, Metronidazole)
Tetracyclines
- Pg 25: Tetracyclines (Part 1)
- Pg 25: Tetracyclines (Part 2) “Adverse reactions & interactions)
Antifungal Drugs
- Pg 26: Miconazole
Antiviral Drugs
- Pg 26: Guanine Analogues – part 1
- Pg 27: Guanine Analogues – part 2
NSAIDs (Nonsteroidal anti-inflammatory drugs)
- Pg 27: NSAIDs – General Considerations -Part 1
- Continued NSAIDs – General Considerations -Part 2
- PG 28: NSAIDs Adverse Effects
- Pg 29: NSAIDs- Table 2 (Adverse effects)
- Pg 29: Box 5 Risk factors for NSAID-induced upper gastrointestinal bleeding or perforation
Paracetamol
- Pg 30: Paracetamol – General Considerations (part1)
- Continued: Paracetamol – General Considerations (part2)
- Tg pg 30: Paracetamol- Adverse effects + Overdose
Opioids
- Pg 31: Opioids- General Considerations
- Pg 32: Opioids – Adverse effects
- Pg 32: Codeine
- Pg 33: Table 3 (Adverse effects of opioids)
Corticosteroids
- Pg 34: Intradental corticosteroids
- Pg 36: Table 4 (Properties of topical corticosteroids used on the oral mucosa)
- Pg 37: Corticosteroids -General Considerations
- Pg 38 Box 6 (Points to consider when prescribing topical intraoral corticosteroids)
- Pg 38: Corticosteroids- Adverse effects
- Pg 40: Systemic corticosteroids
Anxiolytics and Sedative Drugs
- Pg 40: Introduction
- Pg 41: Benzodiazepines- General Considerations
- Pg 41: Benzodiazepines- Adverse Effects
- Pg 42: Diazepam and Temazepam
Mouthwashes
- Pg 44: Chlorhexidine
- Pg 45: Povidone-iodine
- Pg 45: Triclosan
- Pg 45: Benzydamine
Local Anaesthesia
- pg 111: Introduction
- Pg 112: LA Pharmacology -part 1
- Pg 112: LA Pharmacology – part 2
- Pg 112: Addition of Vasoconstrictors – Introduction
- Pg 112: Adrenaline (addition of vasoconstrictors)
- Pg 113: Felypressin – part 1
- Continued: Felypressin – part 2 (pregnancy)
- Pg 114: LA Adverse effects – part 1
- Pg 114: Prilocaine and Articaine Can Cause Methemoglobinemia
- Pg 115: LA Systemic Toxicity
- Pg 116 Choosing a LA: Lignocaine and Prilocaine – part 1
- Pg 116: Lignocaine and Prilocaine – part 2
- Pg 116: Articaine
- Pg 117: Mepivacaine and Bupivacaine
- Pg 117: Ropivacaine
- Pg 118: Table 9 (Maximum safe doses of local anaesthetics)
Open All · Close All